{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:46:40Z","timestamp":1787068000233,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2016YFC1306900"],"award-info":[{"award-number":["2016YFC1306900"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.schres.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T22:02:10Z","timestamp":1520546530000},"page":"390-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia"],"prefix":"10.1016","volume":"199","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiuFeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoduo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2018.03.003_bb0005","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","article-title":"A novel mechanism of action of tetracyclines: effects on nitric oxide synthases","volume":"93","author":"Amin","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2018.03.003_bb0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-5793(97)00605-4","article-title":"Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines","volume":"410","author":"Amin","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.schres.2018.03.003_bb0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia: definition and reliability","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2018.03.003_bb0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","article-title":"The many faces of nitric oxide in schizophrenia. A review","volume":"78","author":"Bernstein","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2018.03.003_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2015.08.013","article-title":"The effect of striatal dopamine depletion on striatal and cortical glutamate: a mini-review","volume":"65","author":"Caravaggio","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.03.003_bb0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.schres.2018.03.003_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2014.12.026","article-title":"The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia","volume":"167","author":"Cohen","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/clinchem\/36.8.1440","article-title":"Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method","volume":"36","author":"Cortas","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.schres.2018.03.003_bb0050","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV)","author":"First","year":"1996"},{"key":"10.1016\/j.schres.2018.03.003_bb0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Garrido-Mesa","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1872213X08666141029123524","article-title":"Minocycline as add-on treatment decreases the negative symptoms of schizophrenia; a randomized placebo-controlled clinical trial","volume":"8","author":"Ghanizadeh","year":"2014","journal-title":"Recent Patents Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.schres.2018.03.003_bb0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamapsychiatry.2013.1292","article-title":"Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Hallak","year":"2013","journal-title":"JAMA psychiatry"},{"key":"10.1016\/j.schres.2018.03.003_bb0070","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.13049su1c.03","article-title":"Assessing disability in schizophrenia: tools and contributors","volume":"75","author":"Harvey","year":"2014","journal-title":"The Journal of clinical psychiatry"},{"key":"10.1016\/j.schres.2018.03.003_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.03.003_bb0080","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/JCP.0000000000000345","article-title":"Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms","volume":"35","author":"Kelly","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.03.003_bb0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.psychres.2013.12.051","article-title":"Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study","volume":"215","author":"Khodaie-Ardakani","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0090","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","article-title":"Inflammation and schizophrenia","volume":"39","author":"Kirkpatrick","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.03.003_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0920-9964(98)00034-6","article-title":"The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6","volume":"32","author":"Lin","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2014.01.011","article-title":"Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial","volume":"153","author":"Liu","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/JCP.0000000000000258","article-title":"The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study","volume":"35","author":"Maia-de-Oliveira","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.03.003_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.schres.2018.03.003_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.03.003_bb0120","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/0269881113503506","article-title":"Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathways","volume":"27","author":"Monte","year":"2013","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.schres.2018.03.003_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.1102","article-title":"Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study","volume":"25","author":"Nakano","year":"2010","journal-title":"Human psychopharmacology"},{"key":"10.1016\/j.schres.2018.03.003_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2015.00139","article-title":"Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects","volume":"6","author":"Nasyrova","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.schres.2018.03.003_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0920-9964(97)00059-5","article-title":"A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?","volume":"26","author":"Naudin","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hup.2426","article-title":"Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Oya","year":"2014","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.schres.2018.03.003_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbagen.2012.01.011","article-title":"Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition","volume":"1820","author":"Pang","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.schres.2018.03.003_bb0150","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1471-4159.2004.02796.x","article-title":"Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways","volume":"91","author":"Pi","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.schres.2018.03.003_bb0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2015.09.045","article-title":"The role of nitric oxide donors in schizophrenia: basic studies and clinical applications","volume":"766","author":"Pitsikas","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2018.03.003_bb0160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.03.003_bb0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0920-9964(03)00070-7","article-title":"Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study","volume":"68","author":"Ramirez","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11011-015-9764-z","article-title":"On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system","volume":"31","author":"Saeedi Saravi","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.schres.2018.03.003_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naive, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2018.03.003_bb0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/10715760500053651","article-title":"Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids","volume":"39","author":"Tsikas","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.schres.2018.03.003_bb0185","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/NDT.S64236","article-title":"Profile of minocycline and its potential in the treatment of schizophrenia","volume":"10","author":"Zhang","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418301518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418301518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T14:23:45Z","timestamp":1660573425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418301518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":37,"alternative-id":["S0920996418301518"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.03.003","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}